Ajuba: a new microtubule-associated protein that interacts with BUBR1 and Aurora B at kinetochores in metaphase

被引:20
作者
Ferrand, Alexia [1 ,2 ]
Chevrier, Veronique [1 ,2 ]
Chauvin, Jean-Paul [2 ,3 ]
Birnbaum, Daniel [1 ]
机构
[1] INSERM, Ctr Rech Cancerol Marseille, Oncol Mol Lab, UMR891,Inst Paoli Calmettes, F-13009 Marseille, France
[2] Univ Aix Marseille 2, F-13284 Marseille, France
[3] Inst Biol Dev Marseille Luminy, UMR 6216, Case 907, F-13288 Marseille, France
关键词
aneuploidy; cell division; checkpoint; microtubule-associated protein; mitosis; SPINDLE CHECKPOINT; LIM PROTEIN; FISSION YEAST; MITOTIC CHECKPOINT; HELA-CELLS; CENP-E; COMPLEX; ATTACHMENT; CANCER; CYTOSKELETON;
D O I
10.1042/BC20080060
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background information. The role of the LIM-domain-containing protein Ajuba was initially described in cell adhesion and migration processes and recently in mitosis as an activator of the Aurora A kinase. Results. In the present study, we show that Ajuba localizes to centrosomes and kinetochores during mitosis. This localization is microtubule-dependent and Ajuba binds microtubules in vitro. A microtubule regrowth assay showed that Ajuba follows nascent microtubules from centrosomes to kinetochores. Owing to its contribution to mitotic commitment and its microtubule-dependent localization, Ajuba could also play a role during the metaphase-anaphase transition. We show that Ajuba interacts with Aurora B and BUBR1 [BUB (budding uninhibited by benomyl)-related 1], two major components of the mitotic checkpoint. Inhibition of BUBR1 by siRNA (small interfering RNA) disrupts chromosome alignment at the metaphase plate and modifies Ajuba localization due to premature mitotic exit. Conclusions. Ajuba is a microtubule-associated protein that collaborates with Aurora B and BUBR1 at the metaphase-anaphase transition and this may be important to ensure proper chromosome segregation.
引用
收藏
页码:221 / 235
页数:15
相关论文
共 41 条
[1]   LATS2-Ajuba complex regulates γ-tubulin recruitment to centrosomes and spindle organization during mitosis [J].
Abe, Y ;
Ohsugi, M ;
Haraguchi, K ;
Fujimoto, J ;
Yamamoto, T .
FEBS LETTERS, 2006, 580 (03) :782-788
[2]   Mal3, the fission yeast EB1 homologue, cooperates with Bub1 spindle checkpoint to prevent monopolar attachment [J].
Asakawa, K ;
Toya, M ;
Sato, M ;
Kanai, M ;
Kume, K ;
Goshima, T ;
Garcia, MA ;
Hirata, D ;
Toda, T .
EMBO REPORTS, 2005, 6 (12) :1194-1200
[3]   The spindle checkpoint, aneuploidy, and cancer [J].
Bharadwaj, R ;
Yu, HT .
ONCOGENE, 2004, 23 (11) :2016-2027
[4]   The budding yeast protein kinase Ipl1/Aurora allows the absence of tension to activate the, spindle checkpoint [J].
Biggins, S ;
Murray, AW .
GENES & DEVELOPMENT, 2001, 15 (23) :3118-3129
[5]   STRUCTURAL AND CHEMICAL CHARACTERIZATION OF ISOLATED CENTROSOMES [J].
BORNENS, M ;
PAINTRAND, M ;
BERGES, J ;
MARTY, MC ;
KARSENTI, E .
CELL MOTILITY AND THE CYTOSKELETON, 1987, 8 (03) :238-249
[6]   Cloning, expression, and properties of the microtubule-stabilizing protein STOP [J].
Bosc, C ;
Cronk, JD ;
Pirollet, F ;
Watterson, DM ;
Haiech, J ;
Job, D ;
Margolis, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :2125-2130
[7]   Survivin is required for stable checkpoint activation in taxol-treated HeLa cells [J].
Carvalho, A ;
Carmena, M ;
Sambade, C ;
Earnshaw, WC ;
Wheatley, SP .
JOURNAL OF CELL SCIENCE, 2003, 116 (14) :2987-2998
[8]   The Rho-associated protein kinase p160ROCK is required for centrosome positioning [J].
Chevrier, V ;
Piel, M ;
Collomb, N ;
Saoudi, Y ;
Frank, R ;
Paintrand, M ;
Narumiya, S ;
Bornens, M ;
Job, D .
JOURNAL OF CELL BIOLOGY, 2002, 157 (05) :807-817
[9]   Carcinogenesis and translational controls:: TACC1 is down-regulated in human cancers and associates with mRNA regulators [J].
Conte, N ;
Charafe-Jauffret, E ;
Delaval, B ;
Adélaïde, J ;
Ginestier, C ;
Geneix, J ;
Isnardon, D ;
Jacquemier, J ;
Birnbaum, D .
ONCOGENE, 2002, 21 (36) :5619-5630
[10]   TACC1-chTOG-Aurora A protein complex in breast cancer [J].
Conte, N ;
Delaval, B ;
Ginestier, C ;
Ferrand, A ;
Isnardon, D ;
Larroque, C ;
Prigent, C ;
Séraphin, B ;
Jacquemier, J ;
Birnbaum, D .
ONCOGENE, 2003, 22 (50) :8102-8116